|
Form Serial Number: |
DA20200106E00139
|
1.
Date of relevant event: |
31/12/2019 (dd/mm/yyyy)
|
2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
3.
Stock code: |
02359 |
4.
Name of listed corporation: |
WuXi AppTec Co., Ltd. (無錫藥明康德新藥開發股份有限公司) |
5.
Class of shares: |
A Shares |
6.
Number of issued shares in class: |
1,480,612,971 |
7.
Name of director (English) as printed on HKID Card/Passport: |
(Surname) |
Liu |
(Other names) |
Xiaozhong |
|
|
|
10.
Name of director (Chinese): |
劉曉鐘 |
11.
Chinese Character Code as printed on HKID Card: |
|
|
24.
Details of relevant event: |
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
Long position |
1711 | Miscellaneous Other (you must briefly describe the relevant event in the Supplementary Information box) | |
|
|
|
|
|
|
|
|
Short position |
|
|
|
|
|
|
|
|
|
|
|
25.
Total shares in listed corporation immediately before the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 452,703,276 | 30.84 |
|
|
26.
Total shares in listed corporation immediately after the relevant event: |
| Total number of shares | Percentage figure (%) |
Long position | 452,703,276 | 30.57 |
|
|
27.
Capacity in which interests disclosed in Box 26 are held: |
Code describing capacity | Number of shares |
2501 | Other (you must describe the capacity in the Supplementary Information box) |
| |
|
|
28.
Further information in derivative interests in listed corporation : |
Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| | | | | | | | | | |
|
|
29.
Further information in relation to interests of children under 18 and/or spouse: |
Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
|
30.
Further information in relation to interests of corporations controlled by Director: |
Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
Shanghai Huixiao Chunyi Medical Investment Co., Ltd. (上海暉曉純頤醫療投資有限公司) | 中國(上海)自由貿易試驗區美盛路173號4層4031室 | Xiaozhong Liu | 50.00 | N | |
Jiaxing Yuxiang Investment Partnership (Limited Partnership)(嘉興宇祥投資合夥企業(有限合夥)) | 浙江省嘉興市廣益路883號聯創大廈2號樓5層573室-147 | Shanghai Huixiao Chunyi Medical Investment Co., Ltd. (上海暉曉純頤醫療投資有限公司) | 50.00 | Y | |
Jiaxing Yumin Investment Partnership (Limited Partnership)(嘉興宇民投資合夥企業(有限合夥)) | 浙江省嘉興市廣益路883號聯創大廈2號樓5層573室-149 | Shanghai Huixiao Chunyi Medical Investment Co., Ltd. (上海暉曉純頤醫療投資有限公司) | 50.00 | Y | |
|
|
31.
Further information in relation to interests held by Director jointly with another person: |
Name of joint shareholder | Address | Number of shares |
Ge Li | Addresses of individuals are not displayed. | |
Ning Zhao | Addresses of individuals are not displayed. | |
Zhaohui Zhang | Addresses of individuals are not displayed. | |
|
|
32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
Names of Trust | Address | Status code | Number of shares |
| | | |
|
|
33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
Names of other parties | Address | Number of shares |
| | |
Total number of shares in which a director is interested under sections 317 and 318 | |
|
|
34.
Supplementary information: |
Xiaozhong Liu held his interests in box 26 jointly with another person and through controlled corporations. Unless otherwise specified herein, terms used herein shall have the same meanings as those defined in the circular of WuXi AppTec Co., Ltd. (無錫藥明康德新藥開發股份有限公司) (the "Company") dated October 4, 2019. Registration of a total of 12,942,744 Restricted A Shares under the 2019 A Share Incentive Plan was completed on December 31, 2019.
|
35.
Log/Serial Number of the previous form: |
|
36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
Date of filing this Form 3A: |
06/01/2020 (dd/mm/yyyy)
|
|